The Next Generation of Low Dead Space Disposable Syringes
Every day, hospitals, surgery centers, infusion clinics, and physician offices administer millions of injectable medications. Most healthcare professionals focus on choosing the correct drug, verifying the correct dose, and ensuring patient safety. Far fewer stop to consider what happens to the medication that never reaches the patient.
The answer lies in a little-known design characteristic called syringe dead space.
Syringe dead space is the small volume of medication that remains trapped inside a syringe and needle after the plunger has been fully depressed.
Although the amount appears insignificant, these tiny residual volumes become surprisingly expensive when multiplied across thousands or millions of injections.
For inexpensive medications the loss may be negligible.
For biologics, oncology drugs, hormone therapies, botulinum toxin, specialty injectables, radiopharmaceuticals, and many compounded medications, the financial impact can be substantial.
Researchers from the University of North Carolina at Chapel Hill and RTI International evaluated the cost of medication lost because of syringe dead space.
Their findings demonstrated that low dead-space syringe designs dramatically reduced medication waste compared with conventional detachable needle syringes. The authors concluded that low dead-space designs should become the industry standard for reducing preventable medication waste.
This research confirms something many pharmacists and nurses have observed for years:
Every drop matters.
Medication preparation today often requires multiple devices.
A typical workflow may include:
Each additional component increases:
Healthcare has largely accepted this process because "that's how it's always been done."
But should it?
Instead of asking how to improve another syringe, perhaps the better question is:
Why should a disposable syringe require another device before it can even draw medication?
This question inspired the development of the QD Platform.
The QD Platform integrates vial access directly into the syringe, allowing medication preparation to begin immediately after opening the sterile package. By separating medication preparation from patient injection, each component can be optimized for its intended purpose while reducing unnecessary workflow steps.
A modern medication preparation platform has the potential to:
Reducing medication waste is particularly important in:
As injectable medications continue to become more specialized and more expensive the efficiency of the delivery system becomes increasingly important.
Healthcare has made extraordinary advances in diagnostics, imaging, robotics, and biotechnology.
Yet one of the most commonly used medical devices the disposable syringe has changed remarkably little.
The next generation of medication preparation may not be about adding another accessory.
It may be about redesigning the syringe itself.
The QD Platform represents one vision of that future: a low dead-space medication preparation system designed to simplify workflow, reduce waste, and improve efficiency while remaining compatible with modern clinical practice.
As hospitals continue searching for ways to reduce costs without compromising patient care, the syringe itself may become one of the next great opportunities for innovation.
Views: 2
Tags: Biologics, Compounding Pharmacy, Drug Delivery, Drug Waste, Healthcare Costs, Healthcare Innovation, Hospital Pharmacy, Injectable Medications, Low Dead Space Syringe, Medical Device, More…Medical Engineering, Medical Technology, Medication Preparation, Medication Waste, Nuclear Medicine, Oncology Pharmacy, Patient Safety, Pharmacy Workflow, Syringe Dead Space, Syringe Design
© 2026 Created by Christopher Green.
Powered by
You need to be a member of QD Syringe Systems® to add comments!
Join QD Syringe Systems®